Clinical Practice
Popular
Neeraj Agarwal, MD, FASCO
Rana McKay, MD
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
- MinuteCE®
Winning the Battle Against Side Effects: Adverse Event Management in HSPC
1.00 program creditScott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Aditya Bardia, MD, MPH, FASCO
Aditya Bardia, MD, MPH, FASCO
Erica L. Mayer, MD, MPH
Aditya Bardia, MD, MPH, FASCO
Erica L. Mayer, MD, MPH
- Oncology and Hematology
DESTINY-Breast05 Findings Lead to New Indication for Trastuzumab Deruxtecan as Adjuvant Treatment for Residual Invasive Disease
Sara A. Hurvitz, MD, FACP
- Oncology and Hematology
TROPION-Breast02: Evidence for the Approval of Datopotamab Deruxtecan for Patients With mTNBC Ineligible for Immunotherapy
Tiffany Traina, MD, FASCO
Michael Dolinger, MD, MBA
David T. Rubin, MD
Florence Odufalu, MD
David T. Rubin, MD
Michael Dolinger, MD, MBA
David T. Rubin, MD
Florence Odufalu, MD
David T. Rubin, MD
- MinuteCE®
Translating Advances into Practice: Lessons from Today’s IBD Landscape
2.00 program creditsUgo Iroku, MD, MHS
David T. Rubin, MD
Adam J. Luginbuhl, MD
Jennifer Johnson, MD, PhD
